MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Clinical trials for MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION explained in plain language.
Never miss a new study
Get alerted when new MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION trials appear
Sign up with your email to follow new studies for MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart treatment trial aims to reduce bleeding risk in elderly patients
Disease control Recruiting nowThis international study is testing whether using just one blood-thinning medication is as safe and effective as using two after a specific type of heart artery procedure. It focuses on patients aged 75 and older or those at high risk for bleeding. The goal is to find the best ba…
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Breakthrough hope: new drug aims to lift depression in days, not weeks
Disease control Recruiting nowThis study is testing whether a new, fast-acting drug called (2R,6R)-HNK can help people with major depression who haven't gotten better with standard treatments. Fifty participants will receive intravenous infusions of either the study drug or a placebo over several weeks to see…
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Phase: PHASE2 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Heart surgery drug trial aims to stop Post-Op brain fog
Prevention Recruiting nowThis study is testing whether a sedative drug called dexmedetomidine can prevent long-term memory and thinking problems that sometimes occur after heart surgery. It will involve 2,400 patients aged 60 and older who are having planned heart surgery. Researchers will compare the dr…
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Phase: PHASE4 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Prevention
Last updated Mar 11, 2026 14:53 UTC
-
New injection aims to smooth 'Tech Neck' bands
Symptom relief Recruiting nowThis study is testing an injectable treatment called NT 201 for adults with moderate to severe neck bands. It will compare the treatment to a placebo (inactive) injection to see if it safely reduces the appearance of these bands. About 300 participants will be randomly assigned t…
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Phase: PHASE3 • Sponsor: Merz Aesthetics GmbH • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
New treatment aims to smooth 'Tech Neck' bands
Symptom relief Recruiting nowThis study is testing an injectable treatment to reduce the appearance of moderate to severe neck bands, often called 'platysmal bands.' It will involve 300 adults in the US who will receive either the active treatment or a placebo. The main goal is to see if the treatment is saf…
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Phase: PHASE3 • Sponsor: Merz North America, Inc. • Aim: Symptom relief
Last updated Mar 23, 2026 15:19 UTC
-
Scientists track 500 patients to unlock secrets of mood disorder recovery
Knowledge-focused Recruiting nowThis study aims to understand how people with depression or bipolar disorder respond to their regular treatments. Researchers will observe 500 adults already receiving care, tracking their symptoms weekly for about 12 weeks. The goal is to find patterns that might help predict wh…
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:09 UTC